ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Santhera Pharmaceuticals Holdings Ltd (PK)

Santhera Pharmaceuticals Holdings Ltd (PK) (SPHDF)

9.42
0.00
(0.00%)
Cerrado 02 Marzo 3:00PM

Mejore su cartera: debates en tiempo real e ideas comerciales prácticas.

Estadísticas y detalles clave

Último Precio
9.42
Postura de Compra
9.42
Postura de Venta
9.42
Volume Operado de la Acción
-
0.00 Rango del Día 0.00
9.42 Rango de 52 semanas 11.70
Capitalización de Mercado [m]
Precio Anterior
9.42
Precio de Apertura
-
Hora
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
-
Acciones en circulación
6,181,292
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
1.06
Beneficio por acción (BPA)
8.86
turnover
103.41M
Beneficio neto
54.78M

Acerca de Santhera Pharmaceuticals Holdings Ltd (PK)

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sitio web
Sede
Liestal, Che
Fundado
-
Santhera Pharmaceuticals Holdings Ltd (PK) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker SPHDF. The last closing price for Santhera Pharmaceuticals (PK) was US$9.42. Over the last year, Santhera Pharmaceuticals (PK) shares have traded in a share price range of US$ 9.42 to US$ 11.70.

Santhera Pharmaceuticals (PK) currently has 6,181,292 shares in issue. The market capitalisation of Santhera Pharmaceuticals (PK) is US$58.23 million. Santhera Pharmaceuticals (PK) has a price to earnings ratio (PE ratio) of 1.06.

SPHDF Últimas noticias

No news to show yet.
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10000000CS
40000000CS
120000000CS
26-2.28-19.487179487211.711.79.425009.42CS
52-2.28-19.487179487211.711.79.421679.42CS
156-4.68-33.191489361714.114.16.827510.54529814CS
260-46.28-83.087971274755.71006.8414931.32680033CS

SPHDF - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Santhera Pharmaceuticals (PK)?
El precio actual de las acciones de Santhera Pharmaceuticals (PK) es US$ 9.42
¿Cuántas acciones de Santhera Pharmaceuticals (PK) están en circulación?
Santhera Pharmaceuticals (PK) tiene 6,181,292 acciones en circulación
¿Cuál es la capitalización de mercado de Santhera Pharmaceuticals (PK)?
La capitalización de mercado de Santhera Pharmaceuticals (PK) es USD 58.23M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Santhera Pharmaceuticals (PK)?
Santhera Pharmaceuticals (PK) ha negociado en un rango de US$ 9.42 a US$ 11.70 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Santhera Pharmaceuticals (PK)?
El ratio precio/beneficio de Santhera Pharmaceuticals (PK) es 1.06
¿Cuál es el ratio de efectivo a ventas de Santhera Pharmaceuticals (PK)?
El ratio de efectivo a ventas de Santhera Pharmaceuticals (PK) es 0.56
¿Cuál es la moneda de reporte de Santhera Pharmaceuticals (PK)?
Santhera Pharmaceuticals (PK) presenta sus resultados financieros en CHF
¿Cuál es el último ingresos anual de Santhera Pharmaceuticals (PK)?
El último ingresos anual de Santhera Pharmaceuticals (PK) es CHF 103.41M
¿Cuál es el último beneficio anual de Santhera Pharmaceuticals (PK)?
El último beneficio anual de Santhera Pharmaceuticals (PK) es CHF 54.78M
¿Cuál es la dirección registrada de Santhera Pharmaceuticals (PK)?
La dirección registrada de Santhera Pharmaceuticals (PK) es HAMMERSTRASSE 49, LIESTAL, 4410
¿Cuál es la dirección del sitio web de Santhera Pharmaceuticals (PK)?
La dirección del sitio web de Santhera Pharmaceuticals (PK) es www.santhera.com
¿En qué sector industrial opera Santhera Pharmaceuticals (PK)?
Santhera Pharmaceuticals (PK) opera en el sector PHARMACEUTICAL PREPARATIONS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
STTOSITO Mobile Ltd (CE)
US$ 0.02
(1,999,900.00%)
278
NLVVFNew Leaf Ventures (CE)
US$ 0.0089
(889,900.00%)
6.92k
AAGRAfrican Agriculture Holdings Inc (CE)
US$ 0.008
(799,900.00%)
101
ETBIEastgate Biotech Corporation (CE)
US$ 0.0045
(449,900.00%)
2k
VWESQVintage Wine Estates Inc (CE)
US$ 0.002
(199,900.00%)
3.44k
NEXINexImmune Inc (CE)
US$ 0.0001
(-99.90%)
13.59k
JERTQJER Investors Trust Inc New (CE)
US$ 0.000001
(-99.67%)
10k
AGILQAgileThought Inc (CE)
US$ 0.0001
(-99.10%)
4.7k
GAYGFMontauk Metals Inc (PK)
US$ 0.0012
(-99.08%)
6.25k
IONMAssure Holdings Corporation (CE)
US$ 0.000001
(-99.00%)
112
HMBLHUMBL Inc (PK)
US$ 0.0005
(25.00%)
279.83M
AITXArtificial Intelligence Technology Solutions Inc (PK)
US$ 0.0026
(-3.70%)
123.47M
SPQSSportsQuest Inc (PK)
US$ 0.0001
(-50.00%)
114.57M
BOMObowmo Inc (PK)
US$ 0.0001
(0.00%)
102.85M
VTXBVortex Brands Company (PK)
US$ 0.0001
(0.00%)
101.18M

SPHDF Discussion

Ver más
Renee Renee 2 años hace
SPHDF one for 10 reverse split:

https://otce.finra.org/otce/dailyList?viewType=Symbol%2FName%20Changes
👍️0
beebob77 beebob77 10 años hace
SPHDF is one step ahead in DMD submission!

Check out Santhera Pharm with a 100 - 400% opportunity:
In comparision to the peers PTC or SRPT we have a fair value of 180USD/share without NDA submission.

Expected Upcoming Milestones
Q4 2014 – Start Phase I CALLISTO study for omigapil in CMD.
H1 2015 – CHMP decision on Raxone as an LHON treatment.
H1 2015 – NDA and MAA submission for Raxone/Catena as a DMD treatment.
H1 2015 – NDA submission for Raxone/Catena for LHON.
H2 2015 – Commercial launch of Raxone for LHON in EU.
Q1 2016 – Commercial launch of Raxone/Catena for DMD in US and EU.
H1 2016 – Commercial launch of Raxone/Catena for LHON in US.


DMD - Market Opportunity
The various price points are, on average, between $300,000 and $500,000 per patient per year. If you consider this in terms of the target population, the company estimates there would be about 2,000 patients in the U.S. that would be amenable to Eteplirsen. This translates into a $600 million to $1 billion market opportunity in the U.S. alone. The EU could add 9,000 additional patients as well.

LifeSci Capital Coverage: link

ValualationLAB Analysis: link
👍️0
stocktrademan stocktrademan 11 años hace
$SPHDF recent news/filings

bullish

## source: finance.yahoo.com

Fri, 15 Aug 2014 05:15:00 GMT ~ Santhera Receives CHF 13.4 Million Through Sale of Treasury Shares

[GlobeNewswire] - LIESTAL, Switzerland -- Santhera Pharmaceuticals (SIX:SANN) today announced that it completed the sale of 200,000 registered shares of common stock at an average price of CHF 66.85 per share, a 4.3% premium ...

read full: http://finance.yahoo.com/news/santhera-receives-chf-13-4-051500317.html
*********************************************************


$SPHDF charts



basic chart ## source: eoddata.com



$SPHDF company information

## source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/SPHDF/company-info
Ticker: $SPHDF
OTC Market Place: OTC Pink Current
CIK code: not found
Company name: Santhera Pharmaceuticals Holdings Ltd.
Company website: http://www.santhera.com
Incorporated In: Switzerland


$SPHDF share structure

## source: otcmarkets.com

Market Value: $255,314,992 a/o Aug 18, 2014
Shares Outstanding: 3,660,430 a/o Aug 29, 2011
Float: Not Available
Authorized Shares: Not Available
Par Value: No Par Value
$SPHDF extra dd links

Company name: Santhera Pharmaceuticals Holdings Ltd.
Company website: http://www.santhera.com

## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/SPHDF/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/SPHDF/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=SPHDF+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=SPHDF+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=SPHDF+Industry

## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/SPHDF/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/SPHDF/news - http://finance.yahoo.com/q/h?s=SPHDF+Headlines

## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/SPHDF/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/SPHDF/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/SPHDF/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/SPHDF/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/SPHDF/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/SPHDF/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/SPHDF/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/SPHDF/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=SPHDF+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/SPHDF
DTCC (dtcc.com): http://search2.dtcc.com/?q=Santhera+Pharmaceuticals+Holdings+Ltd.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Santhera+Pharmaceuticals+Holdings+Ltd.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Santhera+Pharmaceuticals+Holdings+Ltd.&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.santhera.com
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.santhera.com#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.santhera.com

## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/SPHDF/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/SPHDF
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/SPHDF/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/SPHDF/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/SPHDF/sec-filings
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/SPHDF/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/SPHDF/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/SPHDF/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/SPHDF/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=SPHDF&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=SPHDF
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/SPHDF/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=SPHDF+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=SPHDF+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=SPHDF
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=SPHDF
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=SPHDF+Cash+Flow&annual

## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/SPHDF/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=SPHDF+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/SPHDF.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=SPHDF
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/SPHDF/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/SPHDF/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/SPHDF/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/SPHDF/insider-transactions

## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/SPHDF
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/SPHDF
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/SPHDF:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=SPHDF
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=SPHDF



$SPHDF DD Notes ~ http://www.ddnotesmaker.com/SPHDF
👍️0

Su Consulta Reciente

Delayed Upgrade Clock